Previous Article | Next Article 
Journal of Clinical Microbiology, May 2000, p. 1866-1868, Vol. 38, No. 5
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Performance of the ImmunoCard STAT! E. coli O157:H7 Test for
Detection of Escherichia coli O157:H7 in Stools
Andrew
Mackenzie,1,*
Elaine
Orrbine,1
Lucie
Hyde,1
Michelle
Benoit,1
Frank
Chan,1
Choong
Park,2
Jessica
Alverson,2
Amy
Lembke,3
Daryl
Hoban,4 and
William
Kennedy5
Child and Youth Clinical Trials Network,
Children's Hospital of Eastern Ontario Research Institute,
Ottawa,1 Health Sciences Centre,
Winnipeg,4 and Isaak Walton Killam
Hospital, Halifax,5 Canada; INOVA
Fairfax Hospital, Falls Church, Virginia2;
and Scottish Rite Children's Hospital, Atlanta,
Georgia3
Received 8 November 1999/Returned for modification 4 January
2000/Accepted 28 February 2000
 |
ABSTRACT |
ImmunoCard STAT! E. coli O157:H7 (Meridian Diagnostics, Inc.,
Cincinnati, Ohio) is a novel rapid (10-min) test for the
presence of Escherichia coli O157:H7 in stools. The test
may be performed either directly on stool specimens or on an overnight
broth culture of stool. In a multicenter prospective study, 14 of
14 specimens positive by culture for E. coli O157:H7
were positive by the ImmunoCard STAT! O157:H7 test, and there were no
false positives from 263 culture-negative specimens. In a retrospective
study, the test was positive in 339 (81%) of 417 stored
culture-positive specimens and the specificity was 95% (98 of 103 specimens). No false positives were associated with alternate stool
pathogens. The ImmunoCard STAT! O157:H7 test has high sensitivity
and specificity.
 |
INTRODUCTION |
Enterohemorrhagic
Escherichia coli (verotoxigenic E. coli [VTEC])
is an important cause of diarrhea. This organism produces toxin
(verotoxin or Shiga-like toxin). Most patients with VTEC infection
recover uneventfully within a few days, but in some cases
(
8%) (10) the diarrhea is followed by hemolytic-uremic syndrome, a life-threatening complication with substantial morbidity in
survivors (6, 11). Worldwide, many serotypes of VTEC
have been described, but in North America one type predominates,
E. coli O157:H7 (2, 3). Because of the potential
seriousness of VTEC infection (1), there is a need for rapid
tests for the presence of VTEC which can be directly applied to stool
specimens. Prospective and retrospective studies using ImmunoCard STAT!
E. coli O157:H7 (ICS; Meridian Diagnostics, Inc., Cincinnati, Ohio), a
new test for O157:H7 VTEC which detects both O157 lipopolysaccharide and H7 protein antigen, are described here.
 |
MATERIALS AND METHODS |
ICS test.
The test kit consists of a plastic holder with a
well in which the stool sample or broth culture is placed (Fig.
1). The test incorporates two antibodies,
one against lipopolysaccharide O157 and the other against flagellar
antigen H7. A suspension of stool (or broth culture) is placed on the
sample pad, under which there is a conjugate pad impregnated with
anti-O157 antibody bound to colloidal gold. Approximately halfway
along, the membrane is impregnated with a transverse band of anti-H7
antibody, and at the distal end of the membrane is a second band
consisting of anti-globulin. When E. coli O157:H7 is present
in the specimen the organisms bind to the colloidal gold particles
which then diffuse to the backing material and along the nitrocellulose
membrane towards the distal end. If the stool is O157:H7 positive, the
colloidal gold particles, with the H7 antigen attached, are bound by
the H7 antibody strip and show as a purple band. The distal band
recognizes the colloidal gold-anti-O157 conjugate and serves as a
control to indicate that the colloidal gold conjugate is active and
that diffusion through the paper strip is complete. The test takes 10 min, and it can be performed either directly on stool or on MacConkey broth culture. For the direct test the stool is suspended in
diluent supplied by the manufacturer and placed in the test well. For
the broth culture test, stool is inoculated into a MacConkey broth and
incubated overnight, and the test performed by placing the broth
culture in the sample well.

View larger version (62K):
[in this window]
[in a new window]
|
FIG. 1.
From left to right, images show a positive result
obtained with a patient specimen (two bands), an uninoculated card, a
positive control with two bands, and a negative control with a single
band demonstrating validity of test (for explanation, see Materials and
Methods).
|
|
Study design.
Two studies were performed, a prospective
clinical study in five centers, and a retrospective study at three
centers using stored frozen stool specimens. In the clinical study both
the direct test and the incubation test were performed. For the direct test stools received without transport medium were diluted 1:15 in the
manufacturer's diluent and specimens in Cary-Blair transport medium
were diluted 1:4. For the incubation test a portion of the stool was
cultured overnight in MacConkey broth and the test was performed
directly on the broth after incubation (dilution, 1:15).
The "gold standard" for evaluation of ICS was culture of
E. coli O157:H7. In each of the five laboratories participating in
the clinical studies, stools were cultured for
E. coli
O157:H7
on sorbitol-MacConkey agar and sorbitol-negative colonies were
identified as O157 by latex agglutination. H7 was identified by
agglutination (four laboratories) or flagellar immobilization
(one
laboratory).
For the retrospective study the direct test only was performed as
described above. A total of 417 stored stool specimens,
culture
positive for
E. coli O157:H7, from the Laboratory Centre
for
Disease Control and from Fairfax Hospital were tested (after
thawing)
with the direct ICS test according to the manufacturer's
instructions.
Negative controls (103 specimens) included 50 specimens
with alternate
pathogens, as follows:
Campylobacter sp., 26 specimens;
Salmonella sp., 9 specimens;
Shigella sp., 3 specimens; non-O157
VTEC, 12 specimens). All specimens had been frozen
for up to 9
years at

20°C.
 |
RESULTS |
The results of the clinical study are shown in Table
1. Twelve of 14 culture-positive stool
specimens were positive by both tests. One specimen was positive after
incubation but negative by the direct test, and this specimen yielded a
single colony of E. coli O157:H7 after an exhaustive search,
in excess of normal clinical routine. One was positive by the direct
test but negative by the incubation test. This specimen also yielded
the organism after an augmented search. A total of 14 of 14 stool
specimens were positive in at least one of the tests (direct or after
incubation). There were no false positives among 263 culture-negative specimens.
Table 2 shows the results of the
retrospective study. The test results were positive for 339 (81%) of
417 culture-positive specimens, and the specificity was 95% 98 of 103 specimens. Of the 339 test-positive specimens, 328 had been frozen
without preservation and 11 had been preserved in Cary-Blair medium.
The day of illness on which the specimen was taken was available for
361 of the 417 culture-positive specimens in the retrospective study.
The direct test result was positive for 85% (269 of 317 specimens) of
stool samples taken on or before the fifth day of illness and for 73% (32 of 44 specimens) stool samples taken on the sixth day or later.
 |
DISCUSSION |
In the clinical study the ICS test result was positive for 14 of
14 culture-positive stools (Table 1). This number suggests a high
sensitivity, when considered with the overall 81% sensitivity demonstrated in the retrospective study, which is probably an underestimate (see below and Table 2). In the clinical specimen for
which the result was negative by the direct test but positive after
incubation, it is likely that initially the number of organisms was too
small to be detected and that the incubation step enhanced the
population of E. coli O157:H7 over the detection threshold. Antibiotic in the specimen might explain the result on the specimen which was positive by the direct test but negative after incubation, although we were not able to verify this. The ICS test requires the
presence of both antigens (O157 and H7), and the capture system requires the structural integrity of the organisms, to ensure the
comigration of the two antigens along the membrane. We suggest that the
organisms were killed and disrupted by incubation with antibiotic,
although enough bacteria were present in the fresh specimen to yield a
positive direct test result. This requirement for the presence of two
separate antigens on intact organisms to yield a positive result is
probably also the explanation for the specificity of the test. Both of
the apparent false-positive results were resolved by an enhanced search
for viable organisms, suggesting that the sensitivity of this test for
this patient population is comparable to that of standard culture. The
specificity of ICS in the clinical study was 100% (263 of 263 specimens).
The sensitivity of the direct test performed on the stored specimens
was 85% for specimens taken on or before the fifth day of illness. The
sensitivity of the test is probably dependent on the number of
organisms present in the specimen submitted; it is likely that storage
conditions had an impact on the number of organisms. Therefore, the
overall sensitivity of 81% on frozen and thawed specimens in the
retrospective study would underestimate the sensitivity of the direct
test in clinical use. It has been demonstrated in cases of VTEC
diarrhea that the number of organisms in the stool decreases
progressively after the first few days of infection (8).
This may be the reason for the lower sensitivity of the test in
specimens taken after the fifth day of the illness. The number of
specimens in Cary-Blair medium was not large enough to demonstrate a
total absence of effect due to this medium, but the numbers in Table 2
do demonstrate that any effect due to Cary-Blair medium is not great.
The absence of false-positive results on the 50 specimens from which
alternate pathogens were isolated is reassuring, particularly in the
case of Campylobacter sp. infections which, like VTEC,
frequently present with bloody diarrhea.
Commercially available rapid tests for VTEC include those which detect
verotoxin in stools or culture supernatants and those which detect
structural bacterial antigen (4, 5, 7, 9). ICS is more
sensitive and specific than the Premier E. coli O157 test previously
reported (7).
The ICS test is simple to perform, the direct test gives a result
within 10 min, and the test will be of particular value in areas where
E. coli O157:H7 is the predominant VTEC serotype. Early
detection of patients at risk will permit closer observation for signs
of the onset of hemolytic-uremic syndrome, and rapid laboratory
diagnosis also facilitates management of outbreaks.
 |
ACKNOWLEDGMENTS |
We acknowledge the help of the following, who supplied the
specimens used in the retrospective study: Nevio Cimolai, British Columbia Children's Hospital, Vancouver, British Columbia, Canada; Chandar Anand, Provincial Laboratory of Public Health for Southern Alberta, Calgary, Alberta, Canada; Robert Rennie, University of Alberta
Hospital, Edmonton, Alberta, Canada; Kathy Manarin, Victoria Hospital
Corporation, London, Ontario, Canada; Fiona Smaill, McMaster University
Medical Centre, Hamilton, Ontario, Canada; Colina Jones, St. Joseph's
Hospital, Hamilton, Ontario, Canada; Mohammed Karmali, The Hospital for
Sick Children, Toronto, Ontario, Canada; Gloria Delisle, Hotel Dieu
Hospital, Kingston, Ontario, Canada; Silvana Trifiro, Montreal
Children's Hospital, Montreal, Quebec, Canada; Lucette Lafleur,
L'Hôpital Sainte Justine, Montreal, Québec, Canada; Louise
Coté, Centre Hôpitalier de L'University de Québec, St. Foy, Québec, Canada; George Nelson, Isaak Walton Killam
Hospital for Children, Halifax, Nova Scotia, Canada; and Jim Flemming, Sir Charles A. Janeway Child Health Centre, St. Johns, Newfoundland, Canada.
This study was funded by Meridian Diagnostics Inc.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Child and Youth
Clinical Trials Network, Children's Hospital of Eastern Ontario
Research Institute, 401 Smyth Rd., Ottawa, ON K1H 8L1, Canada. Phone:
(613) 738-3674. Fax: (613) 738-4800. E-mail:
amackenzie{at}cyctn.on.ca.
 |
REFERENCES |
| 1.
|
Brotman, M.,
R. A. Giannella,
P. F. Alm,
H. Bauman,
A. R. Bennett,
R. E. Black,
C. M. Bruhn,
M. B. Cohen,
S. L. Gorbach,
J. B. Kaper,
M. R. Roberts,
J. L. Staneck,
S. Taylor,
H. F. Troutt,
B. P. Bell,
R. L. Buchanan,
K. Durham,
P. Feng,
C. T. Forman,
R. G. Galler,
R. B. Gravani,
R. B. Hall,
D. D. Hancock,
J. Hollingsworth,
M. A. Karmali, et al.
1995.
Consensus conference statement Escherichia coli O157:H7 infections an emerging national health crisis, July 11-13, 1994.
Gastroenterology
108:1923-1934[CrossRef][Medline].
|
| 2.
|
Griffin, P., and R. Tauxe.
1991.
The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome.
Epidemiol. Rev.
13:60-98[Free Full Text].
|
| 3.
|
Griffin, P. M.
1998.
Epidemiology of Shiga toxin-producing Escherichia coli in humans in the United States, p. 15-22.
In
J. B. Kaper, and A. D. O'Brien (ed.), Escherichia coli O157:H7 and other Shiga toxin-producing E. coli strains. American Society for Microbiology, Washington, D.C.
|
| 4.
|
Karmali, M. A.,
M. Petric, and M. Bielaszewska.
1999.
Evaluation of a microplate latex agglutination method (Verotox-F assay) for detecting and characterizing verotoxins (Shiga toxins) in Escherichia coli.
J. Clin. Microbiol.
37:396-399[Abstract/Free Full Text].
|
| 5.
|
Kehl, K. S.,
P. Havens,
C. E. Behnke, and D. W. K. Acheson.
1997.
Evaluation of the Premier EHEC assay for detection of Shiga toxin-producing Escherichia coli.
J. Clin. Microbiol.
35:2051-2054[Abstract].
|
| 6.
|
Loirat, C.,
E. Sonsino,
M. Moreno,
G. Pillion,
J. C. Mercier,
F. Beaufils, and H. Mathieu.
1984.
Hemolytic-uremic syndrome: an analysis of the natural history and prognostic features.
Acta Paediatr. Scand
73:505-514[Medline].
|
| 7.
|
Mackenzie, A. M. R.,
P. Lebel,
E. Orrbine,
P. C. Rowe,
L. Hyde,
F. Chan,
W. Johnson,
P. N. McLaine, and The Synsorb PK Study Investigators.
1998.
Sensitivities and specificities of Premier E. coli O157 and Premier EHEC Enzyme Immunoassays for diagnosis of infection with verotoxin (Shiga-like toxin)-producing Escherichia coli.
J. Clin. Microbiol.
36:1608-1611[Abstract/Free Full Text].
|
| 8.
|
Pai, C. H.,
R. Gordon,
H. V. Sims, and L. E. Brian.
1984.
Sporadic cases of hemorrhagic colitis associated with Escherichia coli O157:H7.
Ann. Int. Med.
101:738-742.
|
| 9.
|
Park, C. H.,
K. M. Gates,
N. M. Vandel, and D. L. Hixon.
1996.
Isolation of Shiga-like toxin producing Escherichia coli (O157 and non-O157) in a community hospital.
Diagn. Microbiol. Infect. Dis.
26:69-72[CrossRef][Medline].
|
| 10.
|
Rowe, P. C.,
E. Orrbine,
H. Lior,
G. A. Wells,
E. Yetisir,
M. Clulow,
P. N. McLaine, and Investigators of the Canadian Pediatric Kidney Disease Research Center.
1998.
Risk of hemolytic uremic syndrome after sporadic Escherichia coli O157:H7 infection: results of a Canadian collaborative study.
J. Pediatr.
132:777-781[CrossRef][Medline].
|
| 11.
|
Van Dyck, M.,
W. C. Proesmans, and M. Depraetere.
1988.
Hemolytic uremic syndrome in childhood: renal function ten years later.
Clin. Nephrol.
29:109-112[Medline].
|
Journal of Clinical Microbiology, May 2000, p. 1866-1868, Vol. 38, No. 5
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Chisholm, S. A., Watson, C. L., Teare, E. L., Saverymuttu, S., Owen, R. J.
(2004). Non-invasive diagnosis of Helicobacter pylori infection in adult dyspeptic patients by stool antigen detection: does the rapid immunochromatography test provide a reliable alternative to conventional ELISA kits?. J Med Microbiol
53: 623-627
[Abstract]
[Full Text]
-
Ratiner, Y. A., Salmenlinna, S., Eklund, M., Keskimaki, M., Siitonen, A.
(2003). Serology and Genetics of the Flagellar Antigen of Escherichia coli O157:H7a,7c. J. Clin. Microbiol.
41: 1033-1040
[Abstract]
[Full Text]
-
Stapp, J. R., Jelacic, S., Yea, Y.-L., Klein, E. J., Fischer, M., Clausen, C. R., Qin, X., Swerdlow, D. L., Tarr, P. I.
(2000). Comparison of Escherichia coli O157:H7 Antigen Detection in Stool and Broth Cultures to That in Sorbitol-MacConkey Agar Stool Cultures. J. Clin. Microbiol.
38: 3404-3406
[Abstract]
[Full Text]